Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 4285.49 | nM | PubChem BioAssay data set | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 3837.07 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 4305.27 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 3749.73 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 4159.11 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 1972.42 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 1845.02 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 4709.77 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 4931.74 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 3411.93 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 3810.66 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 2133.04 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 3828.25 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 5420.01 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 3404.08 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 3819.44 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 4120.98 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 5382.7 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 7328.25 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 2818.38 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 6251.73 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 3388.44 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 5559.04 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 5675.45 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 4375.22 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 3265.88 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 4456.56 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 7961.59 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 3681.29 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 3863.67 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 4508.17 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 5333.35 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 4255.98 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 3206.27 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 4130.48 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 5260.17 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 3589.22 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 4864.07 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 3647.54 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 4886.52 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 7744.62 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 3198.9 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 5357.97 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 4709.77 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 5688.53 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 9183.33 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 4456.56 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 2877.4 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | IC50 | > | 5000 | nM | 22708987 |
NPT1383 | Cell Line | A2058 | Homo sapiens | IC50 | = | 4200 | nM | 22708987 |
NPT3190 | Cell Line | NHDF | Homo sapiens | IC50 | > | 5000 | nM | 22708987 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC476509 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9441 | High Similarity | NPC74397 |
0.9324 | High Similarity | NPC472421 |
0.9324 | High Similarity | NPC321387 |
0.9324 | High Similarity | NPC327059 |
0.931 | High Similarity | NPC18886 |
0.9306 | High Similarity | NPC476508 |
0.9262 | High Similarity | NPC472636 |
0.9262 | High Similarity | NPC474744 |
0.9262 | High Similarity | NPC472423 |
0.9262 | High Similarity | NPC471675 |
0.9262 | High Similarity | NPC474772 |
0.9241 | High Similarity | NPC276565 |
0.92 | High Similarity | NPC477957 |
0.92 | High Similarity | NPC327269 |
0.92 | High Similarity | NPC473996 |
0.92 | High Similarity | NPC31627 |
0.92 | High Similarity | NPC476238 |
0.9195 | High Similarity | NPC470908 |
0.9178 | High Similarity | NPC112749 |
0.9161 | High Similarity | NPC255801 |
0.9161 | High Similarity | NPC322301 |
0.9156 | High Similarity | NPC92589 |
0.9145 | High Similarity | NPC321372 |
0.9145 | High Similarity | NPC474386 |
0.9145 | High Similarity | NPC474738 |
0.9145 | High Similarity | NPC475797 |
0.9145 | High Similarity | NPC215917 |
0.9145 | High Similarity | NPC10754 |
0.9145 | High Similarity | NPC78554 |
0.9145 | High Similarity | NPC469936 |
0.9145 | High Similarity | NPC474609 |
0.9145 | High Similarity | NPC20530 |
0.9145 | High Similarity | NPC109967 |
0.9145 | High Similarity | NPC129053 |
0.9133 | High Similarity | NPC472580 |
0.9133 | High Similarity | NPC471677 |
0.9122 | High Similarity | NPC47388 |
0.9122 | High Similarity | NPC473133 |
0.9122 | High Similarity | NPC91902 |
0.9122 | High Similarity | NPC202494 |
0.9122 | High Similarity | NPC470670 |
0.9122 | High Similarity | NPC14875 |
0.9079 | High Similarity | NPC279218 |
0.9079 | High Similarity | NPC469934 |
0.9079 | High Similarity | NPC108937 |
0.9073 | High Similarity | NPC285623 |
0.9032 | High Similarity | NPC472346 |
0.9013 | High Similarity | NPC209760 |
0.9013 | High Similarity | NPC100134 |
0.9007 | High Similarity | NPC472422 |
0.9007 | High Similarity | NPC263384 |
0.9007 | High Similarity | NPC244577 |
0.9007 | High Similarity | NPC474023 |
0.9007 | High Similarity | NPC472420 |
0.9007 | High Similarity | NPC474021 |
0.9007 | High Similarity | NPC471676 |
0.9 | High Similarity | NPC307052 |
0.9 | High Similarity | NPC139966 |
0.9 | High Similarity | NPC472628 |
0.8986 | High Similarity | NPC297788 |
0.898 | High Similarity | NPC472344 |
0.898 | High Similarity | NPC130206 |
0.8968 | High Similarity | NPC470810 |
0.8954 | High Similarity | NPC477958 |
0.8954 | High Similarity | NPC470681 |
0.8947 | High Similarity | NPC150123 |
0.8947 | High Similarity | NPC475790 |
0.8947 | High Similarity | NPC138288 |
0.8947 | High Similarity | NPC10807 |
0.8947 | High Similarity | NPC216035 |
0.8947 | High Similarity | NPC56232 |
0.8947 | High Similarity | NPC244583 |
0.8947 | High Similarity | NPC161881 |
0.8947 | High Similarity | NPC210597 |
0.8947 | High Similarity | NPC217149 |
0.894 | High Similarity | NPC321896 |
0.894 | High Similarity | NPC476185 |
0.894 | High Similarity | NPC105136 |
0.8933 | High Similarity | NPC10097 |
0.8933 | High Similarity | NPC168085 |
0.8933 | High Similarity | NPC145467 |
0.8933 | High Similarity | NPC472345 |
0.8926 | High Similarity | NPC127059 |
0.8926 | High Similarity | NPC470910 |
0.8926 | High Similarity | NPC316769 |
0.8926 | High Similarity | NPC285630 |
0.8919 | High Similarity | NPC307895 |
0.8919 | High Similarity | NPC470553 |
0.8917 | High Similarity | NPC471286 |
0.8917 | High Similarity | NPC473009 |
0.8912 | High Similarity | NPC171870 |
0.8904 | High Similarity | NPC240305 |
0.8889 | High Similarity | NPC223701 |
0.8889 | High Similarity | NPC248793 |
0.8889 | High Similarity | NPC180301 |
0.8889 | High Similarity | NPC472583 |
0.8889 | High Similarity | NPC293286 |
0.8889 | High Similarity | NPC7989 |
0.8889 | High Similarity | NPC469405 |
0.8882 | High Similarity | NPC209846 |
0.8882 | High Similarity | NPC254412 |
0.8882 | High Similarity | NPC328740 |
0.8882 | High Similarity | NPC476162 |
0.8882 | High Similarity | NPC319910 |
0.8882 | High Similarity | NPC278476 |
0.8882 | High Similarity | NPC290671 |
0.8882 | High Similarity | NPC477897 |
0.8882 | High Similarity | NPC262038 |
0.8882 | High Similarity | NPC262039 |
0.8882 | High Similarity | NPC289774 |
0.8882 | High Similarity | NPC178484 |
0.8881 | High Similarity | NPC16197 |
0.8874 | High Similarity | NPC473016 |
0.8874 | High Similarity | NPC89442 |
0.8874 | High Similarity | NPC317492 |
0.8867 | High Similarity | NPC308200 |
0.8867 | High Similarity | NPC472627 |
0.8867 | High Similarity | NPC85773 |
0.8861 | High Similarity | NPC473010 |
0.8861 | High Similarity | NPC473908 |
0.8859 | High Similarity | NPC271288 |
0.8859 | High Similarity | NPC288910 |
0.8859 | High Similarity | NPC235217 |
0.8859 | High Similarity | NPC470890 |
0.8859 | High Similarity | NPC131568 |
0.8859 | High Similarity | NPC470554 |
0.8859 | High Similarity | NPC473014 |
0.8859 | High Similarity | NPC118059 |
0.8859 | High Similarity | NPC224714 |
0.8859 | High Similarity | NPC133060 |
0.8859 | High Similarity | NPC131579 |
0.8854 | High Similarity | NPC93215 |
0.8854 | High Similarity | NPC473012 |
0.8854 | High Similarity | NPC472635 |
0.8851 | High Similarity | NPC112829 |
0.8851 | High Similarity | NPC470556 |
0.8846 | High Similarity | NPC472624 |
0.8846 | High Similarity | NPC304839 |
0.8846 | High Similarity | NPC220582 |
0.8846 | High Similarity | NPC328102 |
0.8846 | High Similarity | NPC472631 |
0.8846 | High Similarity | NPC472630 |
0.8844 | High Similarity | NPC477272 |
0.8839 | High Similarity | NPC161650 |
0.8836 | High Similarity | NPC254168 |
0.8836 | High Similarity | NPC248995 |
0.8836 | High Similarity | NPC272844 |
0.8831 | High Similarity | NPC304207 |
0.8831 | High Similarity | NPC207809 |
0.8831 | High Similarity | NPC217706 |
0.8831 | High Similarity | NPC259710 |
0.8831 | High Similarity | NPC111341 |
0.8831 | High Similarity | NPC48579 |
0.8831 | High Similarity | NPC476169 |
0.8831 | High Similarity | NPC304745 |
0.8831 | High Similarity | NPC471116 |
0.8824 | High Similarity | NPC171651 |
0.8824 | High Similarity | NPC243171 |
0.8824 | High Similarity | NPC35567 |
0.882 | High Similarity | NPC477529 |
0.8816 | High Similarity | NPC471115 |
0.8816 | High Similarity | NPC29777 |
0.8812 | High Similarity | NPC102810 |
0.8811 | High Similarity | NPC215875 |
0.8811 | High Similarity | NPC15834 |
0.8808 | High Similarity | NPC39195 |
0.8805 | High Similarity | NPC53640 |
0.88 | High Similarity | NPC474302 |
0.88 | High Similarity | NPC477955 |
0.88 | High Similarity | NPC290133 |
0.88 | High Similarity | NPC472629 |
0.88 | High Similarity | NPC187282 |
0.88 | High Similarity | NPC24136 |
0.8797 | High Similarity | NPC91288 |
0.8792 | High Similarity | NPC96216 |
0.8792 | High Similarity | NPC223812 |
0.8792 | High Similarity | NPC214166 |
0.8792 | High Similarity | NPC77794 |
0.8792 | High Similarity | NPC125894 |
0.8792 | High Similarity | NPC474939 |
0.8792 | High Similarity | NPC81697 |
0.8792 | High Similarity | NPC316816 |
0.8792 | High Similarity | NPC470909 |
0.8792 | High Similarity | NPC184738 |
0.8792 | High Similarity | NPC85162 |
0.8792 | High Similarity | NPC478086 |
0.8792 | High Similarity | NPC278249 |
0.8792 | High Similarity | NPC185276 |
0.8792 | High Similarity | NPC107177 |
0.8792 | High Similarity | NPC33653 |
0.879 | High Similarity | NPC45124 |
0.879 | High Similarity | NPC471211 |
0.879 | High Similarity | NPC312273 |
0.879 | High Similarity | NPC301256 |
0.879 | High Similarity | NPC471212 |
0.879 | High Similarity | NPC472634 |
0.879 | High Similarity | NPC30655 |
0.879 | High Similarity | NPC74854 |
0.8784 | High Similarity | NPC248372 |
0.8784 | High Similarity | NPC285659 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC476509 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8831 | High Similarity | NPD8443 | Clinical (unspecified phase) |
0.8718 | High Similarity | NPD7075 | Discontinued |
0.8693 | High Similarity | NPD4380 | Phase 2 |
0.8649 | High Similarity | NPD2800 | Approved |
0.8645 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8609 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.8526 | High Similarity | NPD7096 | Clinical (unspecified phase) |
0.8487 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.8466 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8462 | Intermediate Similarity | NPD1934 | Approved |
0.8408 | Intermediate Similarity | NPD7819 | Suspended |
0.8389 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8389 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8367 | Intermediate Similarity | NPD6651 | Approved |
0.8366 | Intermediate Similarity | NPD2533 | Approved |
0.8366 | Intermediate Similarity | NPD2532 | Approved |
0.8366 | Intermediate Similarity | NPD2534 | Approved |
0.8365 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8344 | Intermediate Similarity | NPD6801 | Discontinued |
0.8333 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8302 | Intermediate Similarity | NPD3882 | Suspended |
0.8261 | Intermediate Similarity | NPD5494 | Approved |
0.821 | Intermediate Similarity | NPD6959 | Discontinued |
0.82 | Intermediate Similarity | NPD2796 | Approved |
0.8182 | Intermediate Similarity | NPD6799 | Approved |
0.8182 | Intermediate Similarity | NPD3818 | Discontinued |
0.8176 | Intermediate Similarity | NPD2801 | Approved |
0.8171 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8171 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8171 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8165 | Intermediate Similarity | NPD7411 | Suspended |
0.8133 | Intermediate Similarity | NPD1510 | Phase 2 |
0.8108 | Intermediate Similarity | NPD1240 | Approved |
0.8101 | Intermediate Similarity | NPD6599 | Discontinued |
0.8095 | Intermediate Similarity | NPD6559 | Discontinued |
0.8084 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8075 | Intermediate Similarity | NPD7768 | Phase 2 |
0.8065 | Intermediate Similarity | NPD1511 | Approved |
0.8061 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.8024 | Intermediate Similarity | NPD7054 | Approved |
0.8012 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8012 | Intermediate Similarity | NPD7473 | Discontinued |
0.8 | Intermediate Similarity | NPD1607 | Approved |
0.7976 | Intermediate Similarity | NPD7472 | Approved |
0.7963 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7962 | Intermediate Similarity | NPD1512 | Approved |
0.7941 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7882 | Intermediate Similarity | NPD7251 | Discontinued |
0.7857 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7836 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7831 | Intermediate Similarity | NPD6232 | Discontinued |
0.7824 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7806 | Intermediate Similarity | NPD1243 | Approved |
0.7805 | Intermediate Similarity | NPD3749 | Approved |
0.7799 | Intermediate Similarity | NPD920 | Approved |
0.7799 | Intermediate Similarity | NPD5403 | Approved |
0.7756 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7733 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7725 | Intermediate Similarity | NPD5710 | Approved |
0.7725 | Intermediate Similarity | NPD5711 | Approved |
0.7692 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7683 | Intermediate Similarity | NPD5402 | Approved |
0.7677 | Intermediate Similarity | NPD2344 | Approved |
0.7673 | Intermediate Similarity | NPD5401 | Approved |
0.7673 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7662 | Intermediate Similarity | NPD2799 | Discontinued |
0.7658 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7657 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7643 | Intermediate Similarity | NPD3750 | Approved |
0.763 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7616 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7616 | Intermediate Similarity | NPD5953 | Discontinued |
0.7613 | Intermediate Similarity | NPD6100 | Approved |
0.7613 | Intermediate Similarity | NPD6099 | Approved |
0.7613 | Intermediate Similarity | NPD2935 | Discontinued |
0.7613 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7602 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7602 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7584 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7574 | Intermediate Similarity | NPD3926 | Phase 2 |
0.756 | Intermediate Similarity | NPD1247 | Approved |
0.7545 | Intermediate Similarity | NPD919 | Approved |
0.7514 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7486 | Intermediate Similarity | NPD8312 | Approved |
0.7486 | Intermediate Similarity | NPD8313 | Approved |
0.7484 | Intermediate Similarity | NPD2309 | Approved |
0.7468 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7468 | Intermediate Similarity | NPD6355 | Discontinued |
0.7468 | Intermediate Similarity | NPD5124 | Phase 1 |
0.744 | Intermediate Similarity | NPD6234 | Discontinued |
0.7427 | Intermediate Similarity | NPD2403 | Approved |
0.7421 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.741 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7403 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7403 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7401 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7391 | Intermediate Similarity | NPD7390 | Discontinued |
0.7386 | Intermediate Similarity | NPD2313 | Discontinued |
0.7378 | Intermediate Similarity | NPD3226 | Approved |
0.7368 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7368 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7363 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7363 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7353 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7349 | Intermediate Similarity | NPD37 | Approved |
0.7342 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.734 | Intermediate Similarity | NPD7584 | Approved |
0.7325 | Intermediate Similarity | NPD3748 | Approved |
0.7325 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7325 | Intermediate Similarity | NPD7033 | Discontinued |
0.7321 | Intermediate Similarity | NPD4966 | Approved |
0.7321 | Intermediate Similarity | NPD4965 | Approved |
0.7321 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7312 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.731 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7305 | Intermediate Similarity | NPD8455 | Phase 2 |
0.7296 | Intermediate Similarity | NPD2424 | Discontinued |
0.729 | Intermediate Similarity | NPD943 | Approved |
0.7289 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7278 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD7458 | Discontinued |
0.7267 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7263 | Intermediate Similarity | NPD8150 | Discontinued |
0.7256 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.725 | Intermediate Similarity | NPD2654 | Approved |
0.7248 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7241 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7241 | Intermediate Similarity | NPD7228 | Approved |
0.7233 | Intermediate Similarity | NPD2346 | Discontinued |
0.7233 | Intermediate Similarity | NPD6003 | Clinical (unspecified phase) |
0.7233 | Intermediate Similarity | NPD6004 | Phase 3 |
0.7233 | Intermediate Similarity | NPD6005 | Phase 3 |
0.7233 | Intermediate Similarity | NPD6006 | Clinical (unspecified phase) |
0.7233 | Intermediate Similarity | NPD6002 | Phase 3 |
0.7204 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7202 | Intermediate Similarity | NPD5760 | Phase 2 |
0.7202 | Intermediate Similarity | NPD5761 | Phase 2 |
0.7179 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7179 | Intermediate Similarity | NPD1613 | Approved |
0.7173 | Intermediate Similarity | NPD8151 | Discontinued |
0.7171 | Intermediate Similarity | NPD1203 | Approved |
0.7161 | Intermediate Similarity | NPD3268 | Approved |
0.7161 | Intermediate Similarity | NPD1699 | Clinical (unspecified phase) |
0.7159 | Intermediate Similarity | NPD1729 | Discontinued |
0.7143 | Intermediate Similarity | NPD3751 | Discontinued |
0.7134 | Intermediate Similarity | NPD230 | Phase 1 |
0.7134 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7133 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7124 | Intermediate Similarity | NPD2798 | Approved |
0.7112 | Intermediate Similarity | NPD6781 | Approved |
0.7112 | Intermediate Similarity | NPD6778 | Approved |
0.7112 | Intermediate Similarity | NPD6782 | Approved |
0.7112 | Intermediate Similarity | NPD6780 | Approved |
0.7112 | Intermediate Similarity | NPD6779 | Approved |
0.7112 | Intermediate Similarity | NPD6777 | Approved |
0.7112 | Intermediate Similarity | NPD6776 | Approved |
0.711 | Intermediate Similarity | NPD3787 | Discontinued |
0.7098 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.7098 | Intermediate Similarity | NPD7783 | Phase 2 |
0.7097 | Intermediate Similarity | NPD3027 | Phase 3 |
0.709 | Intermediate Similarity | NPD7435 | Discontinued |
0.709 | Intermediate Similarity | NPD7697 | Approved |
0.709 | Intermediate Similarity | NPD7696 | Phase 3 |
0.709 | Intermediate Similarity | NPD7698 | Approved |
0.7079 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7078 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.707 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7059 | Intermediate Similarity | NPD2797 | Approved |
0.7053 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7053 | Intermediate Similarity | NPD7870 | Phase 2 |
0.7051 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.7051 | Intermediate Similarity | NPD6798 | Discontinued |
0.7035 | Intermediate Similarity | NPD5537 | Clinical (unspecified phase) |
0.7032 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7031 | Intermediate Similarity | NPD7701 | Phase 2 |
0.703 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7029 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.701 | Intermediate Similarity | NPD7801 | Approved |
0.7005 | Intermediate Similarity | NPD7699 | Phase 2 |
0.7005 | Intermediate Similarity | NPD7700 | Phase 2 |
0.6995 | Remote Similarity | NPD4287 | Approved |
0.699 | Remote Similarity | NPD7930 | Approved |
0.6988 | Remote Similarity | NPD5049 | Phase 3 |
0.6987 | Remote Similarity | NPD4625 | Phase 3 |
0.698 | Remote Similarity | NPD1548 | Phase 1 |
0.6974 | Remote Similarity | NPD9717 | Approved |
0.6974 | Remote Similarity | NPD1608 | Approved |
0.697 | Remote Similarity | NPD6143 | Clinical (unspecified phase) |
0.6968 | Remote Similarity | NPD2861 | Phase 2 |
0.6964 | Remote Similarity | NPD5808 | Clinical (unspecified phase) |
0.6959 | Remote Similarity | NPD2296 | Approved |
0.6959 | Remote Similarity | NPD7874 | Approved |
0.6959 | Remote Similarity | NPD7875 | Clinical (unspecified phase) |
0.6947 | Remote Similarity | NPD6823 | Phase 2 |
0.6943 | Remote Similarity | NPD3764 | Approved |
0.6943 | Remote Similarity | NPD7585 | Approved |
0.6935 | Remote Similarity | NPD6535 | Approved |
0.6935 | Remote Similarity | NPD6534 | Approved |
0.6932 | Remote Similarity | NPD4575 | Clinical (unspecified phase) |
PubChem CID   | 402434 |
ChEMBL   | CHEMBL1992376 |
ZINC   |
Molecular Weight:   | 570.28 |
ALogP:   | -0.0273 |
MLogP:   | 3.99 |
XLogP:   | 4.335 |
# Rotatable Bonds:   | 24 |
Polar Surface Area:   | 153.75 |
# H-Bond Aceptor:   | 3 |
# H-Bond Donor:   | 5 |
# Rings:   | 3 |
# Heavy Atoms:   | 41 |